1. Home
  2. CKX vs KALA Comparison

CKX vs KALA Comparison

Compare CKX & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKX
  • KALA
  • Stock Information
  • Founded
  • CKX 1930
  • KALA 2009
  • Country
  • CKX United States
  • KALA United States
  • Employees
  • CKX N/A
  • KALA N/A
  • Industry
  • CKX Oil & Gas Production
  • KALA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CKX Energy
  • KALA Health Care
  • Exchange
  • CKX Nasdaq
  • KALA Nasdaq
  • Market Cap
  • CKX 22.6M
  • KALA 26.2M
  • IPO Year
  • CKX 1998
  • KALA 2017
  • Fundamental
  • Price
  • CKX $11.10
  • KALA $18.62
  • Analyst Decision
  • CKX
  • KALA Strong Buy
  • Analyst Count
  • CKX 0
  • KALA 3
  • Target Price
  • CKX N/A
  • KALA $25.00
  • AVG Volume (30 Days)
  • CKX 3.7K
  • KALA 266.2K
  • Earning Date
  • CKX 08-08-2025
  • KALA 11-11-2025
  • Dividend Yield
  • CKX N/A
  • KALA N/A
  • EPS Growth
  • CKX N/A
  • KALA N/A
  • EPS
  • CKX 0.18
  • KALA N/A
  • Revenue
  • CKX $835,960.00
  • KALA N/A
  • Revenue This Year
  • CKX N/A
  • KALA N/A
  • Revenue Next Year
  • CKX N/A
  • KALA N/A
  • P/E Ratio
  • CKX $62.17
  • KALA N/A
  • Revenue Growth
  • CKX N/A
  • KALA N/A
  • 52 Week Low
  • CKX $10.04
  • KALA $2.92
  • 52 Week High
  • CKX $14.00
  • KALA $18.89
  • Technical
  • Relative Strength Index (RSI)
  • CKX 42.98
  • KALA 86.37
  • Support Level
  • CKX $11.05
  • KALA $13.14
  • Resistance Level
  • CKX $12.01
  • KALA $15.66
  • Average True Range (ATR)
  • CKX 0.43
  • KALA 1.56
  • MACD
  • CKX -0.05
  • KALA 0.58
  • Stochastic Oscillator
  • CKX 6.90
  • KALA 97.40

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: